000			02396 a2200745 4500
005			20250517151333.0
264		0	_c20181115
008			201811s 0 0 eng d
022			_a2041-1723
024	7		_a10.1038/ncomms15099 _2doi
040			_aNLM _beng _cNLM
100	1		_ada Silva-Coelho, Pedro
245	0	0	_aClonal evolution in myelodysplastic syndromes. _h[electronic resource]
260			_bNature communications _c04 2017
300			_a15099 p. _bdigital
500			_aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650	0	4	_aAged
650	0	4	_aAngiogenesis Inhibitors _xtherapeutic use
650	0	4	_aBiomarkers, Tumor _xgenetics
650	0	4	_aBone Marrow Cells _xdrug effects
650	0	4	_aClonal Evolution _xdrug effects
650	0	4	_aDisease Management
650	0	4	_aDisease Progression
650	0	4	_aDrug Resistance, Neoplasm _xgenetics
650	0	4	_aFemale
650	0	4	_aFollow-Up Studies
650	0	4	_aGTP Phosphohydrolases _xgenetics
650	0	4	_aGene Expression Regulation, Neoplastic
650	0	4	_aHumans
650	0	4	_aLenalidomide
650	0	4	_aMale
650	0	4	_aMembrane Proteins _xgenetics
650	0	4	_aMiddle Aged
650	0	4	_aMonitoring, Physiologic
650	0	4	_aMutation
650	0	4	_aMyelodysplastic Syndromes _xdrug therapy
650	0	4	_aProto-Oncogene Proteins p21(ras) _xgenetics
650	0	4	_aThalidomide _xanalogs & derivatives
650	0	4	_aTumor Suppressor Protein p53 _xgenetics
650	0	4	_aExome Sequencing
700	1		_aKroeze, Leonie I
700	1		_aYoshida, Kenichi
700	1		_aKoorenhof-Scheele, Theresia N
700	1		_aKnops, Ruth
700	1		_avan de Locht, Louis T
700	1		_ade Graaf, Aniek O
700	1		_aMassop, Marion
700	1		_aSandmann, Sarah
700	1		_aDugas, Martin
700	1		_aStevens-Kroef, Marian J
700	1		_aCermak, Jaroslav
700	1		_aShiraishi, Yuichi
700	1		_aChiba, Kenichi
700	1		_aTanaka, Hiroko
700	1		_aMiyano, Satoru
700	1		_ade Witte, Theo
700	1		_aBlijlevens, Nicole M A
700	1		_aMuus, Petra
700	1		_aHuls, Gerwin
700	1		_avan der Reijden, Bert A
700	1		_aOgawa, Seishi
700	1		_aJansen, Joop H
773	0		_tNature communications _gvol. 8 _gp. 15099
856	4	0	_uhttps://doi.org/10.1038/ncomms15099 _zAvailable from publisher's website
999			_c27100534 _d27100534